1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Ischemic Stroke Diagnostic Equipment Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Ischemic Stroke Diagnostic Equipment by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Ischemic Stroke Diagnostic Equipment by Country/Region, 2018, 2022 & 2029
2.2 Ischemic Stroke Diagnostic Equipment Segment by Type
2.2.1 Thrombotic
2.2.2 Embolic
2.2.3 Others
2.3 Ischemic Stroke Diagnostic Equipment Sales by Type
2.3.1 Global Ischemic Stroke Diagnostic Equipment Sales Market Share by Type (2018-2023)
2.3.2 Global Ischemic Stroke Diagnostic Equipment Revenue and Market Share by Type (2018-2023)
2.3.3 Global Ischemic Stroke Diagnostic Equipment Sale Price by Type (2018-2023)
2.4 Ischemic Stroke Diagnostic Equipment Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Others
2.5 Ischemic Stroke Diagnostic Equipment Sales by Application
2.5.1 Global Ischemic Stroke Diagnostic Equipment Sale Market Share by Application (2018-2023)
2.5.2 Global Ischemic Stroke Diagnostic Equipment Revenue and Market Share by Application (2018-2023)
2.5.3 Global Ischemic Stroke Diagnostic Equipment Sale Price by Application (2018-2023)
3 Global Ischemic Stroke Diagnostic Equipment by Company
3.1 Global Ischemic Stroke Diagnostic Equipment Breakdown Data by Company
3.1.1 Global Ischemic Stroke Diagnostic Equipment Annual Sales by Company (2018-2023)
3.1.2 Global Ischemic Stroke Diagnostic Equipment Sales Market Share by Company (2018-2023)
3.2 Global Ischemic Stroke Diagnostic Equipment Annual Revenue by Company (2018-2023)
3.2.1 Global Ischemic Stroke Diagnostic Equipment Revenue by Company (2018-2023)
3.2.2 Global Ischemic Stroke Diagnostic Equipment Revenue Market Share by Company (2018-2023)
3.3 Global Ischemic Stroke Diagnostic Equipment Sale Price by Company
3.4 Key Manufacturers Ischemic Stroke Diagnostic Equipment Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Ischemic Stroke Diagnostic Equipment Product Location Distribution
3.4.2 Players Ischemic Stroke Diagnostic Equipment Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Ischemic Stroke Diagnostic Equipment by Geographic Region
4.1 World Historic Ischemic Stroke Diagnostic Equipment Market Size by Geographic Region (2018-2023)
4.1.1 Global Ischemic Stroke Diagnostic Equipment Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Ischemic Stroke Diagnostic Equipment Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Ischemic Stroke Diagnostic Equipment Market Size by Country/Region (2018-2023)
4.2.1 Global Ischemic Stroke Diagnostic Equipment Annual Sales by Country/Region (2018-2023)
4.2.2 Global Ischemic Stroke Diagnostic Equipment Annual Revenue by Country/Region (2018-2023)
4.3 Americas Ischemic Stroke Diagnostic Equipment Sales Growth
4.4 APAC Ischemic Stroke Diagnostic Equipment Sales Growth
4.5 Europe Ischemic Stroke Diagnostic Equipment Sales Growth
4.6 Middle East & Africa Ischemic Stroke Diagnostic Equipment Sales Growth
5 Americas
5.1 Americas Ischemic Stroke Diagnostic Equipment Sales by Country
5.1.1 Americas Ischemic Stroke Diagnostic Equipment Sales by Country (2018-2023)
5.1.2 Americas Ischemic Stroke Diagnostic Equipment Revenue by Country (2018-2023)
5.2 Americas Ischemic Stroke Diagnostic Equipment Sales by Type
5.3 Americas Ischemic Stroke Diagnostic Equipment Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Ischemic Stroke Diagnostic Equipment Sales by Region
6.1.1 APAC Ischemic Stroke Diagnostic Equipment Sales by Region (2018-2023)
6.1.2 APAC Ischemic Stroke Diagnostic Equipment Revenue by Region (2018-2023)
6.2 APAC Ischemic Stroke Diagnostic Equipment Sales by Type
6.3 APAC Ischemic Stroke Diagnostic Equipment Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Ischemic Stroke Diagnostic Equipment by Country
7.1.1 Europe Ischemic Stroke Diagnostic Equipment Sales by Country (2018-2023)
7.1.2 Europe Ischemic Stroke Diagnostic Equipment Revenue by Country (2018-2023)
7.2 Europe Ischemic Stroke Diagnostic Equipment Sales by Type
7.3 Europe Ischemic Stroke Diagnostic Equipment Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Ischemic Stroke Diagnostic Equipment by Country
8.1.1 Middle East & Africa Ischemic Stroke Diagnostic Equipment Sales by Country (2018-2023)
8.1.2 Middle East & Africa Ischemic Stroke Diagnostic Equipment Revenue by Country (2018-2023)
8.2 Middle East & Africa Ischemic Stroke Diagnostic Equipment Sales by Type
8.3 Middle East & Africa Ischemic Stroke Diagnostic Equipment Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Ischemic Stroke Diagnostic Equipment
10.3 Manufacturing Process Analysis of Ischemic Stroke Diagnostic Equipment
10.4 Industry Chain Structure of Ischemic Stroke Diagnostic Equipment
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Ischemic Stroke Diagnostic Equipment Distributors
11.3 Ischemic Stroke Diagnostic Equipment Customer
12 World Forecast Review for Ischemic Stroke Diagnostic Equipment by Geographic Region
12.1 Global Ischemic Stroke Diagnostic Equipment Market Size Forecast by Region
12.1.1 Global Ischemic Stroke Diagnostic Equipment Forecast by Region (2024-2029)
12.1.2 Global Ischemic Stroke Diagnostic Equipment Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Ischemic Stroke Diagnostic Equipment Forecast by Type
12.7 Global Ischemic Stroke Diagnostic Equipment Forecast by Application
13 Key Players Analysis
13.1 Abbott Laboratories Ltd.
13.1.1 Abbott Laboratories Ltd. Company Information
13.1.2 Abbott Laboratories Ltd. Ischemic Stroke Diagnostic Equipment Product Portfolios and Specifications
13.1.3 Abbott Laboratories Ltd. Ischemic Stroke Diagnostic Equipment Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Abbott Laboratories Ltd. Main Business Overview
13.1.5 Abbott Laboratories Ltd. Latest Developments
13.2 Medtronic(Covidien)
13.2.1 Medtronic(Covidien) Company Information
13.2.2 Medtronic(Covidien) Ischemic Stroke Diagnostic Equipment Product Portfolios and Specifications
13.2.3 Medtronic(Covidien) Ischemic Stroke Diagnostic Equipment Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Medtronic(Covidien) Main Business Overview
13.2.5 Medtronic(Covidien) Latest Developments
13.3 General Electric Company(GE Healthcare)
13.3.1 General Electric Company(GE Healthcare) Company Information
13.3.2 General Electric Company(GE Healthcare) Ischemic Stroke Diagnostic Equipment Product Portfolios and Specifications
13.3.3 General Electric Company(GE Healthcare) Ischemic Stroke Diagnostic Equipment Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 General Electric Company(GE Healthcare) Main Business Overview
13.3.5 General Electric Company(GE Healthcare) Latest Developments
13.4 Hitachi, Ltd.
13.4.1 Hitachi, Ltd. Company Information
13.4.2 Hitachi, Ltd. Ischemic Stroke Diagnostic Equipment Product Portfolios and Specifications
13.4.3 Hitachi, Ltd. Ischemic Stroke Diagnostic Equipment Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Hitachi, Ltd. Main Business Overview
13.4.5 Hitachi, Ltd. Latest Developments
13.5 Johnson & Johnson
13.5.1 Johnson & Johnson Company Information
13.5.2 Johnson & Johnson Ischemic Stroke Diagnostic Equipment Product Portfolios and Specifications
13.5.3 Johnson & Johnson Ischemic Stroke Diagnostic Equipment Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Johnson & Johnson Main Business Overview
13.5.5 Johnson & Johnson Latest Developments
13.6 Penumbra, Inc.
13.6.1 Penumbra, Inc. Company Information
13.6.2 Penumbra, Inc. Ischemic Stroke Diagnostic Equipment Product Portfolios and Specifications
13.6.3 Penumbra, Inc. Ischemic Stroke Diagnostic Equipment Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Penumbra, Inc. Main Business Overview
13.6.5 Penumbra, Inc. Latest Developments
13.7 Koninklijke Philips N.V.
13.7.1 Koninklijke Philips N.V. Company Information
13.7.2 Koninklijke Philips N.V. Ischemic Stroke Diagnostic Equipment Product Portfolios and Specifications
13.7.3 Koninklijke Philips N.V. Ischemic Stroke Diagnostic Equipment Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Koninklijke Philips N.V. Main Business Overview
13.7.5 Koninklijke Philips N.V. Latest Developments
13.8 Siemens(Siemens International GmbH)
13.8.1 Siemens(Siemens International GmbH) Company Information
13.8.2 Siemens(Siemens International GmbH) Ischemic Stroke Diagnostic Equipment Product Portfolios and Specifications
13.8.3 Siemens(Siemens International GmbH) Ischemic Stroke Diagnostic Equipment Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Siemens(Siemens International GmbH) Main Business Overview
13.8.5 Siemens(Siemens International GmbH) Latest Developments
13.9 Stryker Corporation (Concentric Medical, Inc.)
13.9.1 Stryker Corporation (Concentric Medical, Inc.) Company Information
13.9.2 Stryker Corporation (Concentric Medical, Inc.) Ischemic Stroke Diagnostic Equipment Product Portfolios and Specifications
13.9.3 Stryker Corporation (Concentric Medical, Inc.) Ischemic Stroke Diagnostic Equipment Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Stryker Corporation (Concentric Medical, Inc.) Main Business Overview
13.9.5 Stryker Corporation (Concentric Medical, Inc.) Latest Developments
13.10 Canon Medical Systems Corporation
13.10.1 Canon Medical Systems Corporation Company Information
13.10.2 Canon Medical Systems Corporation Ischemic Stroke Diagnostic Equipment Product Portfolios and Specifications
13.10.3 Canon Medical Systems Corporation Ischemic Stroke Diagnostic Equipment Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Canon Medical Systems Corporation Main Business Overview
13.10.5 Canon Medical Systems Corporation Latest Developments
13.11 Nihon Kohden Corporation
13.11.1 Nihon Kohden Corporation Company Information
13.11.2 Nihon Kohden Corporation Ischemic Stroke Diagnostic Equipment Product Portfolios and Specifications
13.11.3 Nihon Kohden Corporation Ischemic Stroke Diagnostic Equipment Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Nihon Kohden Corporation Main Business Overview
13.11.5 Nihon Kohden Corporation Latest Developments
14 Research Findings and Conclusion
| ※参考情報 虚血性脳卒中診断装置は、脳の血流が一時的または永続的に不足することによって引き起こされる脳卒中、すなわち虚血性脳卒中の診断を行うための医療機器です。脳卒中は、時間に対して非常に敏感な疾患であり、迅速かつ正確な診断が患者の予後を大きく左右します。本装置の目的は、早期に虚血性脳卒中を特定し、適切な治療を迅速に開始することを可能にすることです。 虚血性脳卒中診断装置の特徴として、非侵襲的、迅速性、そして高精度という点が挙げられます。非侵襲的であることは、患者に対する身体的負担を軽減し、安心して検査を受けられることを意味します。また、迅速性は、脳卒中が発生してから治療までの時間を短縮し、より良い治療結果をもたらす上で非常に重要です。高精度な診断が可能なことにより、偽陽性や偽陰性を減少させ、適切な治療法の選択が促進されます。 この診断装置にはいくつかの種類があります。まず一つ目は、CT（コンピュータ断層撮影）装置です。CTスキャンは、脳内の出血や梗塞を可視化するために広く用いられています。CTは、迅速な結果を提供し、救急の現場での採用に適しています。二つ目は、MRI（磁気共鳴画像法）装置です。MRIは、脳の軟部組織を詳細に映し出すことができ、特に早期の虚血性変化を検出する能力に優れています。これにより、診断の精度が高まります。 さらに、Doppler超音波装置も重要な診断機器のひとつです。超音波を使用して血流を評価し、脳血管の状態を確認することができます。特に、頸動脈の狭窄や閉塞を評価するために非常に役立ちます。また、血流の速度や方向を測定することで、脳卒中のリスク要因を特定する手助けにもなります。 虚血性脳卒中診断装置の用途は多岐にわたります。主な目的は、脳卒中の早期発見と、適切な治療判断を行うことです。また、これらの診断装置は、脳卒中患者の経過観察や再発リスクの評価にも使用されます。病院の救急部門では、急性期脳卒中患者の迅速な評価を行うために必須のツールとなっています。 さらに、診断装置は、研究分野においても重要です。新しい治療法や予防策を評価するためには、正確な診断が不可欠だからです。また、脳卒中のメカニズムを理解するための研究にも貢献しています。これにより、今後の治療法の開発に向けた重要なデータが得られることになります。 関連技術としては、AI（人工知能）技術の進展があります。最近の研究では、画像解析におけるAIの利用が進んでおり、CTやMRI画像からの脳卒中の早期発見が期待されています。AIを活用することで、急性期脳卒中の診断精度が向上し、医師の負担軽減にも寄与することができます。また、テレメディスンの発展も見逃せないポイントです。遠隔地での診断支援が可能となり、地域医療の向上にもつながります。 近年では、血液バイオマーカーの研究も進行中で、バイオマーカーを用いた診断が期待されています。これにより、より迅速かつ簡便な血液検査による脳卒中のリスク評価が可能になるかもしれません。 結論として、虚血性脳卒中診断装置は、脳卒中の早期発見と適切な治療を実現するために不可欠な医療機器です。技術の進化により、より高度で迅速な診断が可能となり、今後の医療現場でのさらなる重要性が増すことが期待されます。医療従事者と技術者が連携し、患者にとって最良の結果をもたらすことが求められているのです。 |
